Serum tissue polypeptide-specific antigen is an independent predictor in breast cancer
- 1 March 2014
- journal article
- Published by Elsevier BV in Acta Histochemica
- Vol. 116 (2), 372-376
- https://doi.org/10.1016/j.acthis.2013.09.001
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Preoperative serum tissue polypeptide‐specific antigen is a valuable prognostic marker in breast cancerInternational Journal of Cancer, 2012
- Measuring proliferation in breast cancer: practicalities and applicationsBreast Cancer Research, 2006
- Relationship between the expression of various markers and prognostic factors in breast cancerActa Histochemica, 2005
- Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?Annals of Oncology, 2005
- Clinical utility of cytokeratins as tumor markersClinical Biochemistry, 2004
- Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancerBreast Cancer Research and Treatment, 2001
- The predictive of tumour markers CA 15-3, TPS and CEA in breast cancer recurrenceThe Breast, 2000
- Influence of Neoadjuvant Chemotherapy on Serum Tumor Markers CA 15-3, MCA, CEA, TPS and TPA in Breast Cancer Patients with Operable DiseaseTumor Biology, 1997
- Monoclonal Antibody M3 Used in Tissue Polypeptide–Specific Antigen Assay for the Quantification of Tissue Polypeptide Antigen Recognizes Keratin 18Tumor Biology, 1994
- Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinomas of the uterine cervixCancer, 1989